This post was originally published on this site Veterans Day has come and gone in the U.S. for another year. Proving that we’re a grateful nation, it was punctuated with speeches by dignitaries and pride-filled social media posts dedicated to the fathers, mothers, sisters, and brothers who serve, or have served, in one of the…
Conditions
Conditions
Antioxidant Compound, with Aid of Baker’s Yeast, May Offer Oral Supplement to Offset Alzheimer’s
This post was originally published on this site A natural compound with antioxidative properties that might help to delay the onset of neurodegenerative diseases like Alzheimer’s can now be produced in baker’s yeast, a study reports. This new way of producing ergothioneine, as the compound is known, may lead to a commercially viable new treatment…
UCLA Launches Fundraising Effort for New Research Center for Sarcoidosis, Other Advanced Lung Diseases
This post was originally published on this site The University of California, Los Angeles (UCLA) is launching a fundraising initiative to help improve treatment for advanced lung diseases, including sarcoidosis. The fundraising effort — called the Lung Health Research Accelerator Fund — aims to generate a total $20 million for the creation of a new…
Ninlaro Prolongs Progression-free Survival in Multiple Myeloma Patients Not Given ASCT, Phase 3 Trial Shows
This post was originally published on this site First-line maintenance therapy with Ninlaro (ixazomib) prolongs the time without disease progression in adults with multiple myeloma not treated with an autologous stem cell transplant, meeting its primary goal, data from a Phase 3 trial show. Ninlaro is an oral proteasome inhibitor marketed by Takeda. Proteasome inhibitors block…
UW Scientist Awarded $17.2M Grant to Study Link Between Eye Health and Alzheimer’s
This post was originally published on this site A team led by a University of Washington (UW) School of Medicine scientist will use a $17.2 million National Institute on Aging (NIA) grant to study whether degenerative eye diseases are linked to Alzheimer’s disease (AD). The award went to Cecilia Lee, an assistant professor of ophthalmology. Along…
FDA Approves BeiGene’s Brukinsa to Treat Adults with Mantle Cell Lymphoma
This post was originally published on this site The U.S. Food and Drug Administration (FDA) has granted conditional approval to BeiGene’s Brukinsa (zanubrutinib) as a second-line treatment for adults with mantle cell lymphoma (MCL) who have received at least one prior therapy. According to BeiGene, the medication should become available to patients in the U.S. within…
$1.34M Grant Will Be Used to Broaden Psychosocial Research into Dementia Care
This post was originally published on this site The National Institutes of Health (NIH) has awarded the Alzheimer’s Association $1.34 million to find more evidence-based ways to enhance care and support for those with Alzheimer’s disease (AD) or other dementias, and their care partners. The five-year grant will support a project titled “Leveraging an Interdisciplinary Consortium to…
First Multiple Myeloma Patient Dosed With CAR T-Cell Therapy UCARTCS1 in Phase 1 Trial
This post was originally published on this site The donor-derived, or allogeneic CAR T-cell therapy candidate UCARTCS1 has been administrated to the first patient in an ongoing Phase 1 trial for relapsed/refractory multiple myeloma. The study (NCT04142619), called MELANI-01, plans to enroll up to 18 adults whose multiple myeloma relapsed after prior treatment. It is…
Enrollment Complete for Clinical Trial of LymPro, an Alzheimer’s Investigational Blood Diagnostic Test
This post was originally published on this site The second part of a clinical study evaluating the use of a blood diagnostic test for Alzheimer’s disease — called the Lymphocyte Proliferation Test (LymPro Test) — is now fully enrolled, the trial’s sponsor, Breakthrough Diagnostics, announced. The trial is ongoing at Leipzig University in Germany, and top-line results are expected…
Caregivers’ Priorities Shift During the Holidays
This post was originally published on this site Some of us are still adjusting to writing 2019 on bank checks, and here we are knocking on the door of the holidays. The older we become, the faster the years seem to zoom by. Just yesterday, we were children dreaming of snow at Christmas and our…
EU Advisory Committee Favors Approval of Polivy with MabThera and Bendamustine for Advanced DLBCL
This post was originally published on this site An advisory committee for the European Medicines Agency has recommended the conditional approval of Roche‘s Polivy (polatuzumab vedotin) in combination with MabThera (rituximab) and bendamustine (a chemotherapy) for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for a hematopoietic…
Darzalex Triple Combo Approved in Europe for Myeloma Patients Ineligible for ASCT
This post was originally published on this site The European Commission has approved Darzalex (daratumumab), in combination with Revlimid (lenalidomide) and dexamethasone, as a first-line treatment for adults with multiple myeloma who are ineligible for autologous stem cell transplant (ASCT). The decision was supported by the recent approval recommendation from the Committee for Medicinal Products for Human Use, an arm of the European…